BioCryst Pharmaceuticals | 営業利益





営業利益 変化する 日付
Alnylam Pharmaceuticals USD -29.96M 13.76M 2025-09
BioCryst Pharmaceuticals USD -2.54M 10.23M 2024-12
Chugai Pharma JPY 169.01B 12.52B 2025-12
Daiichi Sankyo JPY 89.54B 42.01B 2025-12
DBV Technologies USD -34.28M 6.83M 2025-09
Enanta Pharmaceuticals USD -23.54M 98.15M 2024-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Glaxosmithkline GBP 3.76B 1.32B 2025-09
Incyte USD 383.88M 47.43M 2025-12
Ionis Pharmaceuticals USD -160.18M 300.02M 2025-09
Karyopharm Therapeutics USD -31.28M 5M 2024-12
Neurocrine Biosciences USD 239.3M 93.7M 2025-09
Novavax USD -134.02M 296.12M 2024-09
PTC Therapeutics USD 3.49M 38.35M 2025-09
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
Ultragenyx Pharmaceutical USD -170.89M 22.68M 2025-09
Vertex Pharmaceuticals USD 1.24B 84.6M 2025-09


BioCryst Pharmaceuticals 営業利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Feb 2026.